{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:03:49Z","timestamp":1784315029930,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00204-026-04382-3","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:40:00Z","timestamp":1778690400000},"page":"3667-3680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rosiglitazone hepatotoxicity resulting from hepatic protein covalent binding derived from its aldehyde metabolite"],"prefix":"10.1007","volume":"100","author":[{"given":"Yanjia","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-2147","authenticated-orcid":false,"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"2","key":"4382_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7326\/0003-4819-132-2-200001180-00006","volume":"132","author":"J Al-Salman","year":"2000","unstructured":"Al-Salman J, Arjomand H, Kemp DG, Mittal M (2000) Hepatocellular injury in a patient receiving rosiglitazone. A case report. Ann Intern Med 132(2):121\u2013124. https:\/\/doi.org\/10.7326\/0003-4819-132-2-200001180-00006","journal-title":"Ann Intern Med"},{"issue":"7","key":"4382_CR2","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1023\/a:1015895925374","volume":"47","author":"HL Bonkovsky","year":"2002","unstructured":"Bonkovsky HL, Azar R, Bird S, Szabo G, Banner B (2002) Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone. Dig Dis Sci 47(7):1632\u20131637. https:\/\/doi.org\/10.1023\/a:1015895925374","journal-title":"Dig Dis Sci"},{"issue":"6","key":"4382_CR3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1476-5381.2012.02079.x","volume":"167","author":"C Charneira","year":"2012","unstructured":"Charneira C, Grilo NM, Pereira SA et al (2012) N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo. Br J Pharmacol 167(6):1353\u20131361. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02079.x","journal-title":"Br J Pharmacol"},{"key":"4382_CR22","doi-asserted-by":"publisher","unstructured":"Charni-Natan M, Goldstein I (2020) Protocol for Primary Mouse Hepatocyte Isolation. STAR protocols 1(2):100086. https:\/\/doi.org\/10.1016\/j.xpro.2020.100086","DOI":"10.1016\/j.xpro.2020.100086"},{"issue":"5","key":"4382_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/00004836-200205000-00021","volume":"34","author":"M Dhawan","year":"2002","unstructured":"Dhawan M, Agrawal R, Ravi J et al (2002) Rosiglitazone-induced granulomatous hepatitis. J Clin Gastroenterol 34(5):582\u2013584. https:\/\/doi.org\/10.1097\/00004836-200205000-00021","journal-title":"J Clin Gastroenterol"},{"key":"4382_CR5","unstructured":"FDA (2023) Drug development and drug interactions|table of substrates, inhibitors and inducers. https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers"},{"issue":"2","key":"4382_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.7326\/0003-4819-132-2-200001180-00005","volume":"132","author":"LM Forman","year":"2000","unstructured":"Forman LM, Simmons DA, Diamond RH (2000) Hepatic failure in a patient taking rosiglitazone. Ann Intern Med 132(2):118\u2013121. https:\/\/doi.org\/10.7326\/0003-4819-132-2-200001180-00005","journal-title":"Ann Intern Med"},{"issue":"7","key":"4382_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/s0002-9343(01)00926-3","volume":"111","author":"HE Gouda","year":"2001","unstructured":"Gouda HE, Khan A, Schwartz J, Cohen RI (2001) Liver failure in a patient treated with long-term rosiglitazone therapy. Am J Med 111(7):584\u2013585. https:\/\/doi.org\/10.1016\/s0002-9343(01)00926-3","journal-title":"Am J Med"},{"issue":"32","key":"4382_CR8","doi-asserted-by":"publisher","first-page":"21837","DOI":"10.1074\/jbc.R700019200","volume":"283","author":"PA Grimsrud","year":"2008","unstructured":"Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA (2008) Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 283(32):21837\u201321841. https:\/\/doi.org\/10.1074\/jbc.R700019200","journal-title":"J Biol Chem"},{"issue":"5","key":"4382_CR9","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1074\/jbc.M113.493650","volume":"289","author":"J Kim","year":"2014","unstructured":"Kim J, Kwak HJ, Cha JY, Jeong YS, Rhee SD, Cheon HG (2014) The role of prolyl hydroxylase domain protein (PHD) during rosiglitazone-induced adipocyte differentiation. J Biol Chem 289(5):2755\u20132764. https:\/\/doi.org\/10.1074\/jbc.M113.493650","journal-title":"J Biol Chem"},{"issue":"3","key":"4382_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1124\/dmd.110.036327","volume":"39","author":"F Li","year":"2011","unstructured":"Li F, Lu J, Wang L, Ma X (2011) CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism. Drug Metab Dispos 39(3):394\u2013401. https:\/\/doi.org\/10.1124\/dmd.110.036327","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"4382_CR11","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1345\/aph.1E072","volume":"38","author":"TR Marcy","year":"2004","unstructured":"Marcy TR, Britton ML, Blevins SM (2004) Second-generation thiazolidinediones and hepatotoxicity. Ann Pharmacother 38(9):1419\u20131423. https:\/\/doi.org\/10.1345\/aph.1E072","journal-title":"Ann Pharmacother"},{"issue":"7","key":"4382_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/01.mcg.0000170768.59696.16","volume":"39","author":"SB Menees","year":"2005","unstructured":"Menees SB, Anderson MA, Chensue SW, Moseley RH (2005) Hepatic injury in a patient taking rosiglitazone. J Clin Gastroenterol 39(7):638\u2013640. https:\/\/doi.org\/10.1097\/01.mcg.0000170768.59696.16","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"4382_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1021\/acs.chemrestox.9b00205","volume":"33","author":"MN Paludetto","year":"2020","unstructured":"Paludetto MN, Stigliani JL, Robert A et al (2020) Involvement of pazopanib and sunitinib aldehyde reactive metabolites in toxicity and drug-drug interactions in vitro and in patient samples. Chem Res Toxicol 33(1):181\u2013190. https:\/\/doi.org\/10.1021\/acs.chemrestox.9b00205","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"4382_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-0034-1375962","volume":"34","author":"A Regev","year":"2014","unstructured":"Regev A (2014) Drug-induced liver injury and drug development: industry perspective. Semin Liver Dis 34(2):227\u2013239. https:\/\/doi.org\/10.1055\/s-0034-1375962","journal-title":"Semin Liver Dis"},{"issue":"3","key":"4382_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbrc.2004.05.072","volume":"319","author":"R Scatena","year":"2004","unstructured":"Scatena R, Bottoni P, Martorana GE et al (2004) Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: biochemical and pharmacological implications. Biochem Biophys Res Commun 319(3):967\u2013973. https:\/\/doi.org\/10.1016\/j.bbrc.2004.05.072","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"4382_CR16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1021\/tx200168d","volume":"24","author":"AF Stepan","year":"2011","unstructured":"Stepan AF, Walker DP, Bauman J et al (2011) Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 24(9):1345\u20131410. https:\/\/doi.org\/10.1021\/tx200168d","journal-title":"Chem Res Toxicol"},{"issue":"10","key":"4382_CR17","doi-asserted-by":"publisher","first-page":"105142","DOI":"10.1016\/j.arabjc.2023.105142","volume":"16","author":"D Tan","year":"2023","unstructured":"Tan D, Ling L, Qin L, Lu Y, Wu D, He Y (2023) Rosiglitazone induces hepatocyte injury by increasing DCA accumulation through OATP1A4 inhibiting in mice. Arab J Chem 16(10):105142. https:\/\/doi.org\/10.1016\/j.arabjc.2023.105142","journal-title":"Arab J Chem"},{"issue":"12","key":"4382_CR18","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1124\/dmd.109.028860","volume":"37","author":"T Usui","year":"2009","unstructured":"Usui T, Mise M, Hashizume T, Yabuki M, Komuro S (2009) Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins. Drug Metab Dispos 37(12):2383\u20132392. https:\/\/doi.org\/10.1124\/dmd.109.028860","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"4382_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/03602532.2024.2376023","volume":"56","author":"S Wang","year":"2024","unstructured":"Wang S, Argikar UA, Chatzopoulou M et al (2024) Bioactivation and reactivity research advances\u20132023 year in review. Drug Metab Rev 56(3):247\u2013284. https:\/\/doi.org\/10.1080\/03602532.2024.2376023","journal-title":"Drug Metab Rev"},{"key":"4382_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116049","author":"S Weber","year":"2022","unstructured":"Weber S, Gerbes AL (2022) Challenges and future of drug-induced liver injury research-laboratory tests. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23116049","journal-title":"Int J Mol Sci"},{"key":"4382_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pharmtox-030220-015007","volume":"61","author":"T Yokoi","year":"2021","unstructured":"Yokoi T, Oda S (2021) Models of idiosyncratic drug-induced liver injury. Annu Rev Pharmacol Toxicol 61:247\u2013268. https:\/\/doi.org\/10.1146\/annurev-pharmtox-030220-015007","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04382-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:35:15Z","timestamp":1784313315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04382-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4382"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04382-3","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}